Objective: To examine the effect of a diet containing a novel legume food ingredient, Australian sweet lupin (Lupinus angustifolius) kernel fibre (LKFibre), compared to a control diet without the addition of LKFibre, on serum lipids in men. Design: Randomized crossover dietary intervention study. Setting: Melbourne, Australia -Free-living men. Subjects: A total of 38 healthy males between the ages of 24 and 64 y completed the intervention. Intervention: Subjects consumed an LKFibre and a control diet for 1 month each. Both diets had the same background menus with seven additional experimental foods that either contained LKFibre or did not. Depending on energy intake, the LKFibre diet was designed to contain an additional 17 to 30 g/day fibre beyond that of the control diet. Results: Compared to the control diet, the LKFibre diet reduced total cholesterol (TC) (mean7s.e.m.; 4.571.7%; P ¼ 0.001), low-density lipoprotein cholesterol (LDL-C) (5.472.2%; P ¼ 0.001), TC: high-density lipoprotein cholesterol (HDL-C) (3.072.0%; P ¼ 0.006) and LDL-C:HDL-C (3.872.6%; P ¼ 0.003). No effects on HDL-C, triacylglycerols, glucose or insulin were observed. Conclusions: Addition of LKFibre to the diet provided favourable changes to some serum lipid measures in men, which, combined with its high palatability, suggest this novel ingredient may be useful in the dietary reduction of coronary heart disease risk.
Introduction
Epidemiological evidence demonstrates the effectiveness of legume consumption on lowering the risk of coronary heart disease (CHD) (Bazzano et al, 2001 ). The regular consumption of legumes is promoted by health organizations in Western countries to reduce the incidence of this disease (Leterme & Munoz, 2002) . Hypercholesterolaemia is a major risk factor for CHD, shown through both prospective (Stamler et al, 1986; Anderson et al, 1987) and intervention studies (LRC-CPPT, 1984; Shepherd et al, 1995) . Dietary modification remains the preferred initial treatment option for improving major lipid risk factors rather than instigating drug therapy (NCEP, 2001; Anderson, 2003) . Jenkins and coworkers recently proposed the 'Portfolio diet' as a new approach to lipid management: the diet utilizes a combination of hypocholesterolaemic agents such as psyllium, oats, nuts, plant sterols and soy protein to provide an additive effect in reducing total and low-density lipoprotein cholesterol (LDL-C), equivalent to first-line drug therapy (Jenkins et al, 2002a (Jenkins et al, , 2003 . Dietary intervention studies have shown that numerous legumes (eg, soy beans, navy beans, field beans, lentils, chickpeas and pinto beans) beneficially modify serum lipids (Jenkins et al, 1983; Anderson et al, 1984 Anderson et al, , 1990 Anderson et al, , 1995 Duane, 1997; Fruhbeck et al, 1997) . In a recent meta-analysis of non-soy legumes, beneficial effects on serum lipids were partly attributed to the dietary fibre component of these legumes (Anderson & Major, 2002) , which was primarily soluble in nature. Novel dietary fibres, such as those from legumes with proven hypocholesterolaemic action and high palatability may be useful additions to Portfolio-style diets.
In general, soluble dietary fibres such as psyllium, pectin and the legume-derived guar gum are considered to be hypocholesterolaemic agents (Brown et al, 1999; Anderson et al, 2000a, b; Jenkins et al, 2002b) . Nevertheless, the ability of these soluble fibres to impact positively on consumer health has been questioned due to difficulties in incorporating them into palatable food products (Jenkins et al, 2002b) . Insoluble dietary fibres such as wheat bran and cellulose are widely used as commercial ingredients for fibre enrichment of food products such as baked goods and breakfast cereals, but have not demonstrated beneficial lipid-modifying effects (Anderson & Chen, 1979) . One commercially successful, primarily insoluble legume fibre ingredient, soy kernel fibre, has been shown to beneficially modify serum lipids, albeit only in hypercholesterolaemic individuals (Schweizer et al, 1983; Tsai et al, 1983; Shorey et al, 1985; Lo et al, 1986; Bakhit et al, 1994) .
Lupin kernel fibre (LKFibre) is a novel food ingredient extracted from the kernel of Australian sweet lupin (Lupinus angustifolius) (ASL). ASL is a legume that is grown in large quantities in Australia and is considered to be underutilized as a human food source, being used mainly as an animal feed (Petterson, 1998) . Nevertheless, lupin is currently receiving international interest as an alternative source of food ingredients for the future. The dietary fibre content of ASL kernels is higher than that of most other legumes, making up around 40% of the kernel weight (Johnson & Gray, 1993; Petterson, 1998; Guillon & Champ, 2002) . LKFibre has been shown to have potential in the manufacturing of palatable fibre-enriched products such as baked goods and pasta (Clark & Johnson, 2002) .
LKFibre is similar to soy kernel fibre in that it has been reported to consist primarily of insoluble cell wall material (Evans & Cheung, 1993) . However, consisting of a rhamnogalactoronan backbone, with side chains consisting predominantly of galactose and arabinose, LKFibre has a chemical structure with similarities to pectin (Evans & Cheung, 1993) , a soluble fibre known to lower cholesterol (Cerda et al, 1988) .
No human studies investigating the effect of LKFibre on serum lipids have been reported; however, a significant reduction in plasma cholesterol was reported in rats consuming this fibre (Evans et al, 1990) . Therefore, the aim of the current study was to compare the effect of a high-fibre diet incorporating LKFibre and a lower fibre diet without LKFibre on serum lipid levels in healthy men. We also wished to determine whether foods containing LKFibre are as palatable as conventional food products within the dietary setting.
Subjects and methods

Subjects
In all, 44 healthy male subjects were recruited through newspaper articles, radio announcements, posted notices and direct personal communication in Melbourne, Australia. After giving written informed consent, volunteers were screened for suitability using a health questionnaire. Exclusion criteria included cigarette smoking; an allergy to any food ingredients used in the study or to legumes such as soy and peanuts; a history of cardiovascular disease or diabetes and use of medications known to affect lipid and carbohydrate metabolism. A total of 38 subjects completed the study. Of the six subject drop outs, two discontinued after 1 week of the LKFibre diet due to feelings of abdominal bloating, and the remainder left at various stages of the study due to personal reasons. The study was conducted according to the Helsinki Declaration of 1975 as revised in 1983. The Deakin University Ethics Committee granted approval for the study.
Experimental design
A single-blind, randomized, crossover, dietary intervention design in free-living subjects was used in this study. The study consisted of two semi-controlled diets, one a high-fibre diet including seven LKFibre-containing experimental foods, and the other a lower fibre control diet of otherwise equivalent nutritional profile but with the seven experimental foods containing no LKFibre. Subjects were block randomized, in groups of four, to one of the diets (LKFibre or control) for a period of 28 days, then returned to their habitual diet for a washout period of a minimum of 28 days before undertaking the alternate 28 day test diet (LKFibre or control). An equal number of subjects (n ¼ 19) completed each diet order.
Venous blood samples were obtained after the subjects had fasted for 10-12 h overnight and were collected immediately before the commencement (day 1), toward the end (day 26) and upon completion (day 29) of each intervention. Questionnaires on perception of satiety and on palatability of the experimental foods were conducted on day 18 of each intervention. Height and weight (after overnight fast, without shoes and in light clothing) were measured during clinic visits immediately before the commencement (day 1) and upon completion (day 29) of each intervention. Researchers also measured subjects' weight on a weekly basis using portable scales. In an attempt to maintain a stable body weight throughout the study, energy intake was adjusted if changes in weight greater than 1 kg/week were observed.
Experimental foods
The LKFibre (Table 1) was manufactured by Food Science Australia (Werribee, Victoria, Australia). The soluble fibre level in the LKFibre was higher than the approximately 10% previously reported (Johnson & Gray, 1993; Petterson, 1998) and may be linked to a modified processing method. The LKFibre and control experimental foods were manufactured by George Weston Foods (Enfield, New South Wales, Australia). To establish the maximum incorporation rate of LKFibre for inclusion in the experimental food formulations, a preliminary sensory evaluation panel (n ¼ 4) was undertaken (data not presented). The selected incorporation rates of LKFibre demonstrating acceptable palatability in the preliminary sensory evaluation panel were as follows: bread (7.5 g LKFibre/100 g); muffin (5.7 g LKFibre/100 g); chocolate brownie (7.1 g LKFibre/100 g); chocolate milk drink (4.1 g LKFibre/100 g); toasted muesli (15.5 g LKFibre/100 g) pasta (12.4 g LKFibre/100 g) and instant mashed potato (17.6 g LKFibre/100 g). The nutrient composition of the experimental foods was directly analysed using standard procedures of the AOAC (AOAC, 1990).
Dietary assessment
Prior to commencement of the study, each participant was provided with a set of electronic scales, measuring cups and a graduated measuring jug, and then trained by researchers in the accurate measurement of the weight or volume of food and drink. Participants were also provided with a food diary that contained detailed instructions on how to record, in as much detail as possible, every item that they ate or drank, how the item was prepared and its accurately measured weight or volume. To provide an estimate of their habitual energy intake and to aid in tailoring individual diets, subjects completed a 4 day weighed food record of their habitual diet (that included one weekend day) prior to commencement of the interventions. In order to assess compliance to prescribed diets, subjects completed a 4 day weighed food record (including one weekend day) during the second week of each intervention. After completion, researchers discussed each food record with the participant, reviewed the information and discussed any unclear or missing information with the participant in order to minimize inaccuracies commonly associated with weighed food records. Weighed food records were analysed using FoodWorks version 3.01, build 472 (Xyris Software, Brisbane, Australia), which incorporates the AusNut database (All Foods, Rev. 14, Food Standards Australia New Zealand, Canberra, Australia). The database was supplemented with the direct analysis of the experimental foods and manufacturers' information for foods not found on the database.
Diets
The energy content of the LKFibre and control diets prescribed to each subject matched that of the subject's habitual diet as determined by the 4 day weighed food record completed prior to the experimental phase of the study. The two prescribed diets were equivalent in macronutrient composition (50-55% available carbohydrate; 25-30% fat; o10% saturated fat; 15-20% protein and o5% alcohol as a percentage of the total energy and o250 mg/day cholesterol), except for dietary fibre. Fatty acid composition of each diet was designed to be equivalent. It may be difficult for subjects with low energy intake to consume the same level of dietary fibre as those with high energy intake. Therefore, to help ensure dietary compliance, the dietary fibre level in each subject's prescribed diet was stratified based on the total prescribed energy: 25 g dietary fibre/day in the control diet and 55 g dietary fibre/day in the LKFibre diet when prescribed energy intake was 49 MJ/day, and 18 g dietary fibre/day in the control diet and 35 g dietary fibre/day in the LKFibre diet when the prescribed energy intake was r9 MJ/ day. The LKFibre experimental foods or their respective controls were incorporated into 3-day rotating menus (Table 2) . Experimental foods were supplied to subjects on a weekly basis. In order to ensure that fatty acid intakes were balanced between interventions, all fats and oils were provided in the form of margarine (Flora Original Spread, Unilever Australasia, Epping, Australia) and vegetable oil (Eta Vegetable Oil, Goodman Fielder Consumer Foods, Macquarie Park, Australia). LKFibre displaced some of the available carbohydrates in the experimental foods, so additional sucrose-based soft drink syrup (cordial base) was prescribed on the LKFibre diet. Detailed written instructions on dietary protocol as well as counselling on a weekly basis by a nutritionist were provided to help maximize compliance. Subjects were instructed to avoid legumes, high-fat foods and known lipid-modifying foods, such as spreads containing phytosterol.
Blood analysis
Serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), triacylglycerols and plasma glucose were measured by enzymatic colourimetric methods using diagnostic kits (Roche, Mannheim, Germany) on a Hitachi 704 autoanalyser (Tokyo, Japan). LDL-C was calculated using Friedewald's equation (Friedewald et al, 1972) . Plasma insulin was measured in duplicate by radioimmunoassay using a Linco Human Insulin Specific RIA Kit (Linco Research Inc., St. Charles, MO, USA). The homeostasis model assessment (HOMA) for insulin resistance was calculated using the formula, HOMA ¼ [fasting insulin (mU/ml) Â fasting glucose (mmol/l)]/22.5, as used by Matthews et al (1985) .
Satiety and palatability questionnaires
Perceptions of satiety were rated retrospectively using a 15 cm structured graphical scale marked with a far left anchor of 'Extremely hungry', followed by anchors 2.5 cm. apart of 'Hungry', 'Semi-hungry', 'No particular feeling', 'Semi-satisfied', 'Satisfied' and 'Extremely satisfied' (Holt et al, 1995) . Participants were asked to mark a position anywhere along the scale that matched their perception of satiety during the previous few days.
General acceptability of all LKFibre and control food products was evaluated retrospectively. Products were rated using a 15 cm structured graphical hedonic scale marked with a far left anchor of 'Extremely unacceptable', followed by anchors 2.5 cm apart of 'Very unacceptable', 'Unacceptable', 'Neither acceptable or unacceptable', 'Acceptable', 'Very acceptable' and 'Extremely acceptable' (Holt et al, 1995; Clark & Johnson, 2002) . Participants were asked to mark a position anywhere along the scale that matched their perception.
Participants' ratings of satiety and acceptability were converted to a numerical score based on distance in millimetres from the far left anchor of the scales.
Statistical analysis
Based on the data of Ashton and Ball (Ashton & Ball, 2000) , it was predicted that a sample size of 40 subjects would be sufficient to detect a change of 5% in total serum cholesterol with a power of 80% and a ¼ 0.05. A total of 44 subjects were recruited to allow for a 10% dropout. Jenkins et al (2002b) .
Paired sample t-tests, or two-related sample non-parametric tests, were used to compare the effect (i) between the dietary interventions on nutrient intakes, body weight, perception of satiety and perceptions of palatability and (ii) within each intervention (day 0 vs mean of days 26 and 29) on biochemical parameters, using SPSS software, version 11.5 (SPSS Inc, Chicago, IL, USA).
Each subject's LKFibre intake was estimated as the total dietary fibre consumed on the LKFibre diet minus that on the control diet. The relationship between LKFibre dose and treatment effect for TC and LDL-C was examined using Pearson's bivariate correlation by the SPSS software. In all analyses, Po0.05 was considered significant, and data are expressed as mean7s.e.m.
Results
The pre-experimental physical characteristics, fasting serum lipid, insulin and plasma glucose measures and serum lipid and HOMA ratios of the 38 subjects who completed the study are given in Table 3 .
During weekly counselling sessions, subjects who completed the study did not report any major concerns regarding either dietary regime. Self-reported dietary intakes during pre-experimental, LKFibre and control diets are given in Table 4 . In comparison to the subjects' pre-experimental diet, intake of protein (% of energy) was higher on the LKFibre diet and intake of available carbohydrate (g/day and % of energy) was higher on the control diet. Intakes of fat (g/day and % of energy), saturated fatty acids (g/day and % of energy), monounsaturated fatty acids (g/day and % of energy) and cholesterol (g/day) were lower on both interventions, whereas intakes of polyunsaturated fatty acids (g/day and % of energy) were higher on both interventions, compared to the pre-experimental diet.
Total dietary fibre intake (g/day) was higher during the LKFibre diet but lower during the control diet compared to the pre-experimental diet.
Comparisons between the self-reported dietary intakes of the two interventions (Table 4) indicated that dietary fibre intake on the LKFibre diet was on average 22.2 g/day higher (Po0.001) than it was on the control diet. No other differences were found in nutrient intakes between the two interventions, apart from a slightly lower (P ¼ 0.001) mean available carbohydrate level (27.2 g/day and 2.9% of energy) and a slightly higher (P ¼ 0.021) mean protein level (0.8% of energy) during the LKFibre diet.
There was no significant change (P40.05) in subject body weight between the start (mean7s.e.m.; LKFibre 84.171.8 kg, control 84.271.9 kg) and end (mean7s.e.m.; LKFibre 84.071.8 kg, control 84.471.8 kg) of either the LKFibre or the control diets and no significant difference was observed between body weights at the end of the two interventions.
Plasma and serum measures Serum lipid, plasma glucose and serum insulin values on control and LKFibre diets are presented in Table 5 . (Matthews et al, 1985) . Compared to baseline values, both dietary interventions significantly reduced TC, LDL-C, TC:HDL-C and LDL-C:HDL-C (Po0.05). Compared to baseline, there was a significant (P ¼ 0.001) reduction in plasma glucose during the control diet, which did not occur on the LKFibre diet.
When compared to the control diet, the LKFibre diet significantly reduced TC (mean7s.e.: 4.571.7%), LDL-C (5.472.2%), TC:HDL-C (3.072.0%) and LDL-C:HDL-C (3.872.7%) ( Table 5 ). There was no difference in HDL-C and triacylglycerols between the two interventions. There was no significant order or carryover effect of diet on the measured variables (P40.05).
When subjects were grouped according to the baseline TC level, no significant effect of diet (P40.05) was seen for TC, LDL-C, HDL-C or triacylglycerols for 'normocholesterolaemic' subjects (baseline TC o5.5 mmol/l, n ¼ 21). In contrast, significantly lower (Po0.05) levels of TC and LDL-C were observed on the LKFibre compared to the control diet for 'mildly to clinically hypercholesterolaemic' subjects (baseline TC 45.5 mmol/l, n ¼ 17).
There was no relationship between daily LKFibre intake and treatment effect for TC (r ¼ 0.173,
There were no differences (P40.05) in plasma glucose concentration, serum insulin concentration or HOMA between the two interventions.
Satiety and palatability questionnaires
There was no significant difference in perception of satiety on day 18 between the LKFibre (mean7s.e.m.: 11.972.3) and control (mean7s.e.m.: 11.172.7) diets (P ¼ 0.400; Wilcoxon signed ranks test 
Discussion
This study demonstrated that the addition of LKFibre to provide on average 22.2 g of extra dietary fibre to the diet reduced TC, LDL-C, TC:HDL-C and LDL:HDL-C without reducing HDL-C, effects which are considered beneficial in reducing CHD risk (NCEP, 2001; NHF, 2001; Mensink et al, 2003) . Based on the 2% reduction in CHD risk for each 1% reduction in LDL-C concentration suggested by LRC-CPPT (1984) , E9% reduction in CHD risk can be predicted based on the mean treatment effect of a 4.5% reduction in TC found in the present study. These effects are similar to those of soluble viscous dietary fibres such as psyllium, guar gum and b-glucans (Brown et al, 1999; Anderson et al, 2000b; Jenkins et al, 2002b; Kerckhoffs et al, 2003) . Nevertheless, studies comparing the effects of LKFibre with those of established cholesterol-lowering fibres, in equi-fibre diets, are now required.
The fact that both interventions were effective in improving the serum lipid profiles compared to the baseline levels (Matthews et al, 1985) .
was not surprising, given these diets more closely matched the macronutrient profiles of established lipid-modifying diets such as the NCEP Step 1 (Yu Poth et al, 1999) than did the subjects' pre-experimental diets.
The apparently differing effects of the LKFibre diet on TC and LDL-C in subjects with normal compared to elevated baseline TC suggests a greater benefit of this fibre for subject with elevated TC levels. Nevertheless, further studies specifically designed to investigate the lipid-modifying effect of LKFibre in hypercholesterolaemic patients are required.
The lack of a correlation between LKFibre intake with TC or LDL-C reduction suggests there was no doseresponse relationship. This finding is contrary to the dose-response relationship reported for oat-bran (Anderson et al, 1984; Davidson et al, 1991) and that suggested by a meta-analysis on the cholesterol-lowering effects of soluble fibre (Brown et al, 1999) . Further studies are required to investigate whether a dose-response relationship exists for the hypocholesterolaemic effect of LKFibre and, in particular, to determine if lower levels of LKFibre intake remain effective.
LKFibre has very high water-binding properties (B11 g water/g fibre) compared to other insoluble dietary fibre food ingredients under conditions simulating the human gastrointestinal tract (Turnbull et al, 2002) . This unusual physicochemical property could underlie a possible mechanism for the beneficial effect of LKFibre on serum lipids, that is, through inhibition of dietary cholesterol absorption and modification to the enterohepatic circulation of bile acids (Anderson et al, 1999) . Further research, for instance investigating the effect of LKFibre on bile acid secretion, is required to confirm this proposed mechanism. A trend towards a higher concentration of propionate and a significantly higher daily output of this short-chain fatty acid was observed during the LKFibre diet rather than during the control diet (Johnson et al, unpublished data) . Therefore, inhibition of hepatic cholesterol production via propionatemediated effects may also help to explain the modified serum lipid profile (Anderson & Chen, 1979) . Considering the well-documented lipid-modifying effects of soy proteins (Anderson et al, 1995) , it is possible that the residual protein present in the LKFibre ingredient may have made a minor contribution to its lipid-modifying effects. Nevertheless, the lipid-modifying effects of lupin protein in humans remain unknown.
Adding LKFibre to the diet did not appear to modify fasting serum insulin concentration, plasma glucose concentration or calculated insulin resistance (HOMA). It should be noted that the mean baseline values for these parameters were in the normal range that would make effects of dietary intervention difficult to observe. In a previous study, the addition of LKFibre to bread did result in a reduced insulinaemic response compared to standard white bread (Johnson et al, 2003) . To further investigate the effect of the long-term consumption of LKFibre on glucose metabolism, the use of a sensitive technique such as the euglycaemic hyperinsulinaemic clamp for the measurement of insulin resistance is suggested.
The physiological benefits of consuming a novel dietary fibre can only be attained if foods incorporating the dietary fibre demonstrate high sensory acceptability. The fact that all of the LKFibre products tested in this study were rated on the acceptable half of the sensory evaluation line scale after repeated consumption suggests that, in general, consumers would not find these products objectionable. The finding that some LKFibre products were rated less acceptable than their respective controls suggests that reformulation at a lower LKFibre incorporation rate may be necessary to obtain optimal product acceptance. From the present study and earlier sensory work (Clark & Johnson, 2002 ), it appears that LKFibre is suitable for incorporation into a range of food matrices and that it may have advantages, in terms of product acceptability, over soluble viscous lipid-lowering dietary fibres (Jenkins et al, 2002b) .
Adding dietary fibre to food products has been reported to increase the food products effects on perception of satiety (Burley & Blundell, 1990) . More specifically, a postprandial study has demonstrated the highly satiating effects of LKFibre, suggesting that it may have potential in obesity-control diets (Archer et al, 2004) . The results of the present study do not support these earlier findings. Nevertheless, the effect of LKFibre on satiety in the long-term dietary setting remains worthy of further investigation.
In conclusion, the results of this study indicate that LKFibre has potential as a hypocholesterolaemic agent, which, combined with its demonstrated high palatability, suggests that this novel fibre may be a valuable addition to current dietary approaches to reduce CHD risk.
